{"task_id": "1811e42f1fbc1ea0", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 191/905)", "text": "eir abdomen, and breathe calmly and appropriately.\n\n--- Page 197 ---\n183\nChest medicine\nTable 4.6 Adult doses of common inhaled drugs used in bronchoconstriction\nInhaled\naerosol\nInhaled\npowder\nNebulized\n(supervised)\nSalbutamol\nDose example:\n100\u2013200mcg/6h\n200\u2013400mcg/6h\n2.5\u20135mg/6h\nAiromir\u00ae is a CFC-free example\nof a breath-actuated inhaler\nTerbutaline\nSingle dose\n500mcg \n2.5mg/mL\nRecommended regimen\n500mcg/6h\n5\u201310mg/6\u201312h\nSalmeterol\nDose/puff \n25mcg\n50mcg\n\u2014\nRecommended regimen\n50\u2013100mcg/12h\n50\u2013100mcg/12h\n\u2014\nTiotropium bromide (COPD)\nDose/puff \n2.5mcg\n9mcg\n\u2014\nRecommended regimen\n25mcg daily\n18mcg daily\n\u2014\nSteroids\n(Clenil Modulite\u00ae=beclometasone; Pulmicort\u00ae=budesonide;* Flixotide\u00ae=\ufb02 uticasone)\nFluticasone (Flixotide\u00ae)\nDoses available/puff \n50, 100, 250, & \n500mcg\nAs for aerosol\n250mcg/mL\nRecommended regimen\n100\u2013250mcg/12h\n100\u2013250mcg/12h\nmax 1mg/12h\n0.5\u20132mg/12h\nClenil Modulite\u00ae\nDoses available/puff \n50 & 100mcg\n\u2014\n\u2014\n250mcg\nRecommended regimen\n200mcg/12h\nthen\n400mcg/12h\nthen\n1000mcg/12h\n*Available as a Turbohaler\u00ae; Autohalers\u00ae are an alternative (breath-actuated) and don\u2019t need breathing \ncoordination, eg Airomir\u00ae (salbutamol) and Qvar\u00ae (beclometasone). Accuhalers\u00ae deliver dry powders \n(eg Flixotide\u00ae, Serevent\u00ae).\nSystemic absorption (via the throat) is less if inhalation is through a large-volume device, eg Volumatic\u00ae or \nAeroChamber Plus\u00ae devices. The latter is more compact. Static charge on some devices reduces dose deliv-\nery, so wash in water before dose; leave to dry (don\u2019t rub). It\u2019s pointless to squirt many puff s into a device: \nit is best to repeat single doses, and be sure to inhale as soon as the drug is in the spacer. SE: local (oral) \ncandidiasis (p377); \ue000rate of cataract if lifetime dose \u22652g beclometasone. 37\n\ue007Prescribe beclometasone by brand name, and state that a CFC-free inhaler should \nbe dispensed. This is because, dose for dose, Qvar\u00ae is twice as potent as the other \navailable CFC-free brand (Clenil Modulite\u00ae).\nAny dose \u2265250mcg \u2248 signi\ufb01 cant steroid absorption: carry a steroid card; this recom-\nmendation is being widened, and lower doses (beclometasone) are now said to merit \na steroid card (manufacturer\u2019s information).", "text_length": 2168, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 191/905)", "type": "chunk", "chunk_index": 190, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:52.261932", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:52.262632", "status": "complete", "chunks_added": 2}